We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Spectral Md Holdings Ltd | SMD | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 58.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 58.00 | 58.00 |
| Industry Sector |
|---|
| HEALTH CARE EQUIPMENT & SERVICES |
| Top Posts |
|---|
Posted at 07/9/2023 15:34 by rimau1 SMD delists tonight and heads across the pond. Whether it closes at 60p, £1 or 20p couldn’t be less relevant. Be a nice chap and just give £20 to charity anyway, call it a fine for having no idea what is happening here. |
Posted at 06/9/2023 15:57 by rimau1 That is a complicated question that would require a very long response and i suppose means you don’t understand the structure of the transaction. SMD have a good presentation on their website. Highly unlikely to double but could get a decent kicker if rosecliff (who are being paid a few million quid) manage to raise new funds at the top of the $10m-$30m range. |
Posted at 06/9/2023 15:37 by rimau1 I suppose RCLF with announce it today and SMD via an rns either at 5pm or tomorrow? I listened in to the meeting, vote was passed. No idea when if gets physically announced! Trading starts Friday. |
Posted at 22/8/2023 08:48 by idomeneo WH Island note: "The proposed merger EV also stands at a discount to our sum-of-the-parts fair valuation of SMD of 157p per share" |
Posted at 10/8/2023 10:47 by rimau1 8th september for the delisting on AIM and listing on Nasdaq. SMD shareholders will own £17m ordinary shares in the new company at $10.17 a share. Obviously the stock could tank on relisting and it might be a few days before broking accounts are updated to trade the new shares but there is a theoretical paper profit of 100% at todays prices. |
Posted at 01/8/2023 08:35 by rimau1 New presentation released which provides a good investment case, clear why Rosecliff are willing to pay a premium to snare SMD. |
Posted at 23/6/2021 05:13 by rambutan2 Conclusiona from the Experts Report pgs70-91, which is very well worth a read:7. Conclusions Development and commercialisation of new medical devices in healthcare is a high-risk activity but when executed successfully can deliver significant rewards. For SMD to achieve its potential as a provider of medical devices in the wound healing sector, assuming that the DFU and burns clinical trials are successful, its commercial success will rely to a greater degree on adoption and penetration into US and EU markets. This will require significant sales and marketing efforts in penetrating clinical networks in both territories as well as successfully navigating the various regulatory and payer communities. The Company is cognisant of these requirements and appears to have appropriate plans to address these, some of which have already been or are being implemented. Many of the technical and development risks appear to have been addressed through the evolution of the system through 1st and 2nd generation systems. Final proving of the 3rd generation system’s capabilities has yet to be completed which is the purpose of the ongoing and planned clinical trials. If the system performs as expected in those trials, there appear to be few if any competing systems in the market or late-stage development that can provide the same analytical and predictive capabilities of the Deepview® device. Whilst this does not guarantee commercial success, it would mean that the device would likely be regarded best in class in a clinical setting with limited diagnostic capability. The future development plans and commercialisation of its technology in different markets will likely mean that SMD will require further funding beyond that provided under the BARDA agreement and any funds from a successful new issue on AIM. Whilst there is no guarantee that such future funding will materialise, good clinical data from the ongoing and planned clinical trials will position it well for regulatory and commercial success. |
Posted at 22/6/2021 15:19 by rambutan2 Admission to trading on AIM& First Day of Dealings LONDON, U.K. AND DALLAS, TX, U.S. Spectral MD Holdings, Ltd., a predictive analytics group that develops proprietary AI algorithms and optical technology for faster treatment decisions in wound care, is pleased to announce the admission of its entire issued share capital, being 136,077,064 shares of common stock, to trading on AIM ("Admission") will take place and dealings will commence at 8.00 a.m. today under the ticker 'SMD' and ISIN 'USU8457V1099'. The Company's Admission Document was published on 16 June 2021 and is available here: Summary and Highlights: -- Oversubscribed Placing for gross proceeds of GBP11.3 million (c.US$16 million) -- The Placing was conducted at a pre-IPO fully diluted valuation of GBP95m -- Placing price per share of common stock of 59 pence -- Market capitalisation (at the Placing Price) of approximately GBP80 million on Admission -- The 19,067,797 shares of New Common Stock being placed represent c. 14 per cent. of the Enlarged Share Capital |
Posted at 03/12/2020 02:01 by stu31 Strategic Metals Ltd. Announces New Normal Course Issuer Bid to Succeed the Normal Course Issuer Bid Which Will Expire on December 2, 2020Vancouver, BC - November 30, 2020 – Strategic Metals Ltd. (TSX-V: SMD) (“Strategic Strategic has purchased no shares under the Old Bid, which will expire on December 2, 2020. The New Bid will consist of the acquisition by Strategic of up to 8,700,000 common shares of its capital stock, representing approximately 10% of the “public float” of 87,599,346 common shares upon the date of commencement of the New Bid. (There are currently 106,705,767 common shares of Strategic issued and outstanding.) The New Bid will commence on December 3, 2020, and will expire on December 2, 2021. Strategic is making the New Bid, to succeed the Old Bid (which was limited to an aggregate of 6,600,000 common shares), because it is of the opinion that fluctuating global market conditions periodically (and currently) may result in unwarranted reductions in Strategic’s share price that do not reflect the underlying value of its assets. Strategic will utilize unallocated cash resources to effect purchases under the New Bid with a view to capitalizing on these potential price weaknesses. Shares purchased under the New Bid will be made at Management’s discretion based on market conditions, and will be returned to Strategic’s treasury for cancellation. |
Posted at 15/8/2020 01:12 by stu31 Strategic Metals: Latest on Mt. Hinton & high-grade opportunitiesby @JamesKwantes on 4 Aug 2020, 11:29 I caught up with Strategic Metals $SMD CEO Doug Eaton recently to talk about Mt. Hinton and other irons in the fire. Two diamond drills are turning at Mt. Hinton, an area of high-grade gold and silver mineralization in Yukon's Keno Hill district adjacent to Alexco's property. Strategic plans a 7,000-metre drill program and Eaton expects that drilling could continue into early October this season. The recently closed $4-million financing gives Strategic the capacity to expand - even double - the program, results and weather permitting. With gold near US$2,000 an ounce, the timing couldn't be better. Strategic is a pretty compelling sum-of-the parts story beyond its wholly owned Mt. Hinton project. The company, one of three Resource Opportunities sponsors, has about $12 million in cash and roughly $27 million in shareholdings (current SMD market cap $77 million). Strategic also has about 80 wholly owned precious metals projects available for option, several of which Eaton says are high-quality enough standalone projects for a company to go public on. 00:00 Introduction 00:16 Mt. Hinton plans and drill progress 06:00 Under the hood, Part 1: Major SMD shareholdings and upcoming catalysts 06:30 Rockhaven Resources: New PEA, large drilling program possible 08:11 Precipitate Gold: Barrick JV and drilling on wholly owned project in DR 08:35 Trifecta Gold: Drill permitting underway for Yuge project in Nevada 08:50 GGL Resources: B.C. project w/ porphyry/epithermal targets, new Nevada acquisition 10:55 Under the hood, Part 2: Precious metals properties available for option 12:09 Plata: High-grade silver plus gold; past producer 15:06: Alotta: Porphyry/vein targets; 40 km from Western's Casino deposit 16:24 Hopper: Porphyry target with similarities to Casino 18:02 Groundhog: High-grade silver prospect w/ gold 19:37 Gold price and market sentiment |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
